Does subcutaneous testosterone pellet therapy cause supraphysiologic peaks and later troughs that affect mood and cause androgenic side effects?

The pharmacokinetics of subcutaneous testosterone pellet therapy in women are characterized by a distinct pattern of initial surges followed by a gradual decline, which can have significant implications for mood and physical side effects.

Pharmacokinetic profile

Evidence from clinical monitoring protocols confirms that testosterone pellets produce a unique delivery curve compared to other forms of hormone replacement.

• Supraphysiologic Peaks: Immediately following implantation, pellets often undergo a "burst release" from their surface. In clinical studies, this frequently results in serum testosterone levels peaking between 100-250 ng/dL within the first 2–4 weeks. These levels significantly exceed the normal premenopausal physiological range of 15-70 ng/dL.
• Subsequent Troughs: After the initial peak, testosterone levels gradually decline over a 4-to-6-month cycle as the pellet dissolves. This leads to a trough (Cmin) toward the end of the treatment period, necessitating re-implantation to avoid the return of deficiency symptoms.

Mechanistic and clinical effects

The fluctuations associated with these peaks and troughs are linked to both psychological and dermatological changes through established endocrine pathways.

• Mood Instability: Supraphysiologic levels and high testosterone-to-estradiol ratios are mechanistically linked to mood disruptions. Research suggests these fluctuations may alter serotonin transporter activity and disrupt gonadotropin-releasing hormone (GnRH) signaling, potentially leading to irritability or depressive symptoms similar to those seen in endogenous hyperandrogenism (e.g., PCOS).
• Androgenic Side Effects: Rapid increases in serum testosterone directly stimulate sebaceous glands and hair follicles. The conversion of excess testosterone to dihydrotestosterone (DHT) triggers increased sebum production and male-pattern hair growth (hirsutism). These effects are most pronounced when levels exceed the therapeutic window during the initial post-implantation peak.

Bottom line

Testosterone pellet therapy is scientifically supported to cause supraphysiologic peaks followed by gradual troughs. While many women experience symptom relief, these fluctuations are mechanistically linked to mood instability and androgenic side effects like acne and hirsutism, requiring careful monitoring of peak and trough levels to maintain a stable therapeutic range.